Gerald Mader, MD
Family Medicine · Whiteland, INNPI 1922174234
Payments from drug & device makers
Across 633 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$2K
- GSK$1K
- Novo Nordisk$1K
- Takeda Pharmaceuticals U.S.A., Inc.$421
- Lilly USA, LLC$406
- plus $3K from 31 others
What the payments were for
- Food & beverage$10,003100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 233 | $2,308 |
| AstraZeneca | 35 | $1,607 |
| GSK | 69 | $1,303 |
| Novo Nordisk | 69 | $1,042 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $421 |
| Lilly USA, LLC | 27 | $406 |
| Vanda Pharmaceuticals Inc. | 21 | $334 |
| Pfizer | 19 | $243 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $234 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $230 |
| Boehringer Ingelheim | 15 | $229 |
| Abbott | 4 | $199 |
| Amgen | 3 | $157 |
| Supernus Pharmaceuticals, Inc. | 9 | $146 |
| Amarin Pharma, Inc. | 7 | $110 |
| Dexcom, Inc. | 5 | $99 |
| Bausch Health US, LLC | 6 | $97 |
| Axonics, Inc. | 2 | $86 |
| Antares Pharma, Inc. | 6 | $85 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Merck | 5 | $78 |
| Almatica Pharma LLC | 3 | $62 |
| Axsome Therapeutics, Inc. | 4 | $59 |
| Astellas Pharma US Inc | 4 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $53 |
| Johnson & Johnson | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$478
- TRELEGY ELLIPTA$250
- FREESTYLE LIBRE 3$150
- AIRSUPRA$125
- Repatha$121
- Ozempic$105
How this compares
$10,020 in reported general payments places this provider in the 90th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $88,234 |
| VraylarCariprazine Hcl | 43 | $77,809 |
| MounjaroTirzepatide | 52 | $69,795 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $39,839 |
| EliquisApixaban | 18 | $30,173 |
| XareltoRivaroxaban | 19 | $26,898 |
| FarxigaDapagliflozin Propanediol | 28 | $26,881 |
| JardianceEmpagliflozin | 12 | $18,973 |
| TrintellixVortioxetine Hydrobromide | 25 | $15,088 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $10,654 |
| LinzessLinaclotide | 15 | $10,222 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $9,902 |
| Paroxetine Hcl | 29 | $9,822 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,619 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 250 | $6,070 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,042 | $88,23462 claims |
| AbbVieVraylar, Linzess | $2,308 | $88,03158 claims |
| Lilly USA, LLCMounjaro | $406 | $69,79552 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,303 | $45,35053 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,607 | $36,50044 claims |
| PfizerEliquis | $243 | $30,17318 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $229 | $29,62727 claims |
| Johnson & JohnsonXarelto | $42 | $26,89819 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $421 | $15,08825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Whiteland
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.